ProCE Banner Activity

Answering the Questions on Rapid ART Initiation

Video

Hear from expert faculty as they discuss questions about rapid ART initiation for HIV including guideline recommendations, data to support improved clinical outcomes, and rapidly transitioning from PrEP to ART after HIV seroconversion.

Released: April 10, 2023

Share

Faculty

Isolde F. Butler

Isolde F. Butler, MD, MPH

Chief Medical Officer
Crescent Care
New Orleans, Louisiana 

Brenda E. Crabtree Ramírez

Brenda E. Crabtree Ramírez, MD

Assistant Professor, HIV Program
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Mexico City, Mexico

Provided by

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine whether and how to implement rapid ART in newly diagnosed people with HIV

Disclosure

Primary Author

Isolde F. Butler, MD, MPH

Chief Medical Officer
Crescent Care
New Orleans, Louisiana 

Isolde F. Butler, MD, MPH, has no relevant financial relationships to disclose.

Contributing Author

Brenda E. Crabtree Ramírez, MD

Assistant Professor, HIV Program
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Mexico City, Mexico

Brenda E. Crabtree Ramírez, MD, has no relevant financial relationships to disclose.

Format

The program has been made available online.